Joincare Pharmaceutical Group Industry Co Ltd (600380) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Joincare Pharmaceutical Group Industry Co Ltd (600380) has a cash flow conversion efficiency ratio of 0.045x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥1.09 Billion ≈ $159.61 Million USD) by net assets (CN¥24.08 Billion ≈ $3.52 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 600380 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Joincare Pharmaceutical Group Industry Co Ltd - Cash Flow Conversion Efficiency Trend (1999–2025)
This chart illustrates how Joincare Pharmaceutical Group Industry Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Joincare Pharmaceutical Group Industry Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Joincare Pharmaceutical Group Industry Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ZIM Integrated Shipping Services Ltd.
F:2SV
|
0.093x |
|
Wesdome Gold Mines Ltd.
TO:WDO
|
0.168x |
|
GCL System Integration Technology Co Ltd
SHE:002506
|
0.162x |
|
TP ICAP GROUP PLC LS -25
F:8D7
|
N/A |
|
Aerospace Auto
SHG:600151
|
0.024x |
|
HEXPOL AB (publ)
ST:HPOL-B
|
0.066x |
|
Veidekke ASA
OL:VEI
|
0.397x |
|
Ermenegildo Zegna NV
NYSE:ZGN
|
0.111x |
Annual Cash Flow Conversion Efficiency for Joincare Pharmaceutical Group Industry Co Ltd (1999–2025)
The table below shows the annual cash flow conversion efficiency of Joincare Pharmaceutical Group Industry Co Ltd from 1999 to 2025. For the full company profile with market capitalisation and key ratios, see Joincare Pharmaceutical Group Industry C market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥24.37 Billion ≈ $3.57 Billion |
CN¥3.89 Billion ≈ $569.50 Million |
0.160x | +2.78% |
| 2024-12-31 | CN¥23.40 Billion ≈ $3.42 Billion |
CN¥3.64 Billion ≈ $532.11 Million |
0.155x | -10.46% |
| 2023-12-31 | CN¥22.64 Billion ≈ $3.31 Billion |
CN¥3.93 Billion ≈ $574.92 Million |
0.174x | -3.93% |
| 2022-12-31 | CN¥22.02 Billion ≈ $3.22 Billion |
CN¥3.98 Billion ≈ $582.06 Million |
0.181x | +42.22% |
| 2021-12-31 | CN¥20.18 Billion ≈ $2.95 Billion |
CN¥2.56 Billion ≈ $375.06 Million |
0.127x | -19.23% |
| 2020-12-31 | CN¥19.24 Billion ≈ $2.81 Billion |
CN¥3.02 Billion ≈ $442.65 Million |
0.157x | +18.21% |
| 2019-12-31 | CN¥17.38 Billion ≈ $2.54 Billion |
CN¥2.31 Billion ≈ $338.38 Million |
0.133x | +18.75% |
| 2018-12-31 | CN¥16.30 Billion ≈ $2.38 Billion |
CN¥1.83 Billion ≈ $267.13 Million |
0.112x | -18.44% |
| 2017-12-31 | CN¥13.62 Billion ≈ $1.99 Billion |
CN¥1.87 Billion ≈ $273.69 Million |
0.137x | -22.04% |
| 2016-12-31 | CN¥9.33 Billion ≈ $1.37 Billion |
CN¥1.64 Billion ≈ $240.65 Million |
0.176x | +1.80% |
| 2015-12-31 | CN¥7.31 Billion ≈ $1.07 Billion |
CN¥1.26 Billion ≈ $185.05 Million |
0.173x | +15.58% |
| 2014-12-31 | CN¥6.54 Billion ≈ $957.23 Million |
CN¥979.46 Million ≈ $143.33 Million |
0.150x | +41.93% |
| 2013-12-31 | CN¥6.02 Billion ≈ $881.55 Million |
CN¥635.52 Million ≈ $93.00 Million |
0.105x | -19.69% |
| 2012-12-31 | CN¥5.59 Billion ≈ $818.10 Million |
CN¥734.36 Million ≈ $107.46 Million |
0.131x | +10.27% |
| 2011-12-31 | CN¥5.46 Billion ≈ $798.94 Million |
CN¥650.36 Million ≈ $95.17 Million |
0.119x | -42.70% |
| 2010-12-31 | CN¥5.32 Billion ≈ $778.05 Million |
CN¥1.11 Billion ≈ $161.74 Million |
0.208x | +51.08% |
| 2009-12-31 | CN¥4.40 Billion ≈ $644.12 Million |
CN¥605.66 Million ≈ $88.63 Million |
0.138x | +16.78% |
| 2008-12-31 | CN¥3.86 Billion ≈ $565.10 Million |
CN¥455.01 Million ≈ $66.58 Million |
0.118x | +11.73% |
| 2007-12-31 | CN¥4.07 Billion ≈ $595.64 Million |
CN¥429.26 Million ≈ $62.81 Million |
0.105x | +11.54% |
| 2006-12-31 | CN¥2.88 Billion ≈ $421.74 Million |
CN¥272.50 Million ≈ $39.88 Million |
0.095x | -21.15% |
| 2005-12-31 | CN¥3.03 Billion ≈ $443.13 Million |
CN¥363.13 Million ≈ $53.14 Million |
0.120x | +47.47% |
| 2004-12-31 | CN¥2.97 Billion ≈ $434.97 Million |
CN¥241.71 Million ≈ $35.37 Million |
0.081x | +43.15% |
| 2003-12-31 | CN¥3.03 Billion ≈ $443.74 Million |
CN¥172.25 Million ≈ $25.21 Million |
0.057x | -51.61% |
| 2002-12-31 | CN¥2.01 Billion ≈ $294.39 Million |
CN¥236.13 Million ≈ $34.55 Million |
0.117x | +3.91% |
| 2001-12-31 | CN¥1.98 Billion ≈ $289.91 Million |
CN¥223.79 Million ≈ $32.75 Million |
0.113x | -83.03% |
| 2000-12-31 | CN¥257.75 Million ≈ $37.72 Million |
CN¥171.61 Million ≈ $25.11 Million |
0.666x | +15.13% |
| 1999-12-31 | CN¥189.89 Million ≈ $27.79 Million |
CN¥109.82 Million ≈ $16.07 Million |
0.578x | -- |
About Joincare Pharmaceutical Group Industry Co Ltd
Joincare Pharmaceutical Group Industry Co.,Ltd. engages in the research, development, production, and sale of pharmaceuticals and health care products in China and internationally. The company offers chemical pharmaceuticals for respiratory, gastroenterology, assisted reproduction, psychiatry, and anti-infection; chemical APIs and intermediates for drugs for humans and veterinary drugs; and tradi… Read more